Skin biopsy samples obtained from SSc patients showed the increased population of IL-17+ cells compared to those of healthy controls, and IL-17 attenuated the myofibroblast transdifferentiation, suggesting its antifibrotic role during dermal fibrosis in SSc (11). The gene discussed is IL17A; the disease is systemic sclerosis.